Elevate the pace, performance, and culture of your company's greatest assets. Built from over 30 years of success with more than 7,500 graduates from over 1,000 life science companies, From the Laboratory to Leadership program guides first-time managers, and those seeking to expand their management skills, into capable business leaders. This fully redesigned program leverages..
Join BioIVT and France Tissue Bank experts to explore how high-quality biospecimens, longitudinal data, and regulatory rigor drive the future of biomarker discovery. Using an Alzheimer’s disease use case, discover the critical role of pre-analytical rigor, matched sample sets, and demographic diversity. Learn to navigate ISO standards, optimize sample selection for AI and clinical diagnostics,..
What does it really take to build a successful strategic partnership in life sciences? For today’s business development leaders, identifying which opportunities will genuinely help accelerate growth can be challenging. In this dynamic program, attendees will hear from Johnson & Johnson’s External Innovation Group deal-making experts, who will provide strategic guidance on core collaboration capabilities..
Elevate the pace, performance, and culture of your company's greatest assets. Built from over 30 years of success with more than 7,500 graduates from over 1,000 life science companies, From the Laboratory to Leadership program guides first-time managers, and those seeking to expand their management skills, into capable business leaders. This fully redesigned program leverages..
Biopharma Technology, LLC, is hosting a 3-day product, process, and systems workshop, from April 7th to April 9th,2026 at the modern Future Facility™ at Open Biopharma Research and Training Institute in Carlsbad. With over 18 hours of lyophilization content, this 3-day comprehensive lyo training course provides an opportunity to explore a wide range of elements..
It’s both an incredibly exciting and challenging time for the life science industry. Some companies are enjoying tailwinds as the result of great clinical data, their proximity to product approval, or they find themselves in a hot therapeutic space. Others, may be more challenged, as access to capital remains difficult, putting their progress through the..
One‑day symposium to bring together leading experts to discuss the rapidly evolving landscape of in vivo CAR-T. In vivo CAR-T has attracted significant attention from venture capital and the pharmaceutical industry. By offering the potential to overcome some of the most persistent constraints of ex vivo CAR-T, including expensive and complex workflows and limited scalability,..
There is no cost for attendees. From big data to fast action. Learn how the fusion of high-throughput automation and AI is transforming traditional labs into autonomous engines of innovation. Enjoy beer & wine and tasty appetizers while seeing the latest life science products and technologies from 40 suppliers. Keynote speaker will be Will Serber,..
Is your AI strategy ready for high-stakes R&D decisions? 🤖🔬 In the complex world of drug discovery, the difference between a breakthrough and a bottleneck often comes down to how we use data. But as the volume of research grows, how do we move beyond the hype of AI to find actionable intelligence? Join Digital..